Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Clinical trial NCT06371417 · RECRUITING

Trial details

NCT number: NCT06371417
Sponsor: Chugai Pharmaceutical
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)Dermatomyositis (DM)Immune-mediated Necrotizing Myopathy (IMNM)Immune Thrombocytopenia (ITP)

Start date: 2024-08-19
Primary completion: 2027-03-31
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.